View Author
patient cancer study treatment chemotherapy tumor survival carcinoma surgery trial response group grade esophageal month death result resection effect paclitaxel intervention oncol toxicity esophageal cancer lymph follow-up phase disease cycle adenocarcinoma therapy score analysis table pharmacokinetic number chemoradiotherapy neoadjuvant level function carboplatin cisplatin radiotherapy metastatic metastase pancreatic plasma randomized center symptom diarrhea infusion lymph nodes rotterdam signi cell carcinoma pki 166 preoperative combination difference esophagus quality oncology docetaxel change regimen tumour event oesophageal netherland supraclavicular lymph nodes baseline pancreatic cancer ctcae r 101933 neoadjuvant chemoradiotherapy value consequence signi ficantly range
10 Most Recent Publications
|
Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study
(Article)
Hagen, P. van Spaander, V.M.C.W. Gaast, A. van der Rij, C.M. van Tilanus, H.W. Lanschot, J.J.B. van Wijnhoven, B.P. |
2011-12-22
|
|
Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: Long-term results of a randomized controlled trial
(Article)
Boonstra, J.J. Kok, T.C. Siersema, P.D. Wijnhoven, B.P.L. Heijl, M. van Berge Henegouwen, M.I. van Kate, F.J.W. ten Dinjens, W.N.M. Lanschot, J.J.B. van Tilanus, H.W. Gaast, A. van der |
2011-05-19
|
|
Phase II trial of Uracil/Tegafur plus leucovorin and celecoxib combined with radiotherapy in locally advanced pancreatic cancer
(Article)
Morak, M.J.M. Richel, D.J. Eijck, C.H.J. van Nuyttens, J.J.M.E. Gaast, A. van der Verwenne, W.L. Padmos, E.E. Schaake, E.E. Busch, O.R.C. Tienhoven, G. van |
2011-02-01
|
|
Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer
(Article)
Heijl, M. van Omloo, J.M. Nieuwenhuijzen, G.A.P. Bonenkamp, J. Plukker, J.T. Cuesta, M.A. Kate, F.J.W. ten Pruim, J. Dekken, H. van Bergman, J.J.G.H.M. Sloof, G.W. Lanschot, J.J.B. van Berge Henegouwen, M.I. van Hoekstra, O.S. Boellaard, R. Bossuyt, P.M.M. Busch, O.R.C. Tilanus, H.W. Hulshoff, M. Gaast, A. van der |
2011-01-01
|
|
Phase i and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours
(Article)
Konings, I.R.H.M. Jonge, M.J.A. de Burger, H. Gaast, A. van der Beijsterveldt, L.E.C. van Winkler, H. Verweij, J. Yuan, Z. Hellemans, P. Eskens, F.A.L.M. |
2010-09-28
|
|
The addition of pravastatin to chemotherapy in advanced gastric carcinoma: A randomised phase II trial
(Article)
Konings, I.R.H.M. Gaast, A. van der Wijk, L.J. Jongh, F.E. de Eskens, F.A.L.M. Sleijfer, S. |
2010-08-19
|
|
Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Review of Meta-Analyses
(Article)
Wijnhoven, B.P.L. Lanschot, J.J.B. van Tilanus, H.W. Steyerberg, E.W. Gaast, A. van der |
2009-12-01
|
|
Chemotherapy followed by surgery in patients with carcinoma of the distal esophagus and celiac lymph node involvement.
(Article)
Boonstra, J.J. Koppert, L.B. Wijnhoven, B.P.L. Tilanus, H.W. Dekken, H. van Tran, T.C. Gaast, A. van der |
2009-10-01
|
|
Pathological analysis after neoadjuvant chemoradiotherapy for esophageal carcinoma: The Rotterdam experience
(Article)
Meerten, E. van Gaast, A. van der Tilanus, H.W. Poley, J.W. Muller, K. Dekken, H. van |
2009-07-01
|
|
Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: A randomised trial
(Article)
Verschuur, E.M.L. Steyerberg, E.W. Tilanus, H.W. Polinder, S. Essink-Bot, M.L.E. Tran, K.T.C. Gaast, A. van der Stassen, L.P. Kuipers, E.J. Siersema, P.D. |
2009-01-13
|
